Lambert-Eaton Myasthenic Syndrome - 11 Studies Found
| No longer available |
: Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome : Lambert-Eaton Myasthenic Syndrome : 2011-06-13 : Drug: 3,4 DAP Recommended maximum dosage: 20mg four times daily and if needed an additional 20 mg per da |
| Recruiting |
: Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS) : Lambert-Eaton Myasthenic Syndrome : 2016-11-16 :
|
| Completed |
: A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS) : Lambert Eaton Myasthenic Syndrome : 2011-06-17 :
|
| Available |
: Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine : Lambert-Eaton Myasthenic Syndrome : 2009-10-08 : Drug: 3,4 diaminopyridine 3,4 diaminopyridine up to 80 mg daily in divided doses |
| Available |
: Treatment of Lambert-Eaton Syndrome With 3,4 DAP : Lambert Eaton Myasthenic Syndrome : 2008-06-23 : Drug: 3, 4 DAP Patients with clinically-confirmed LEMS will receive 3, 4 DAP by mouth in slowly increasi |
| No longer available |
: Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome : : 2024-11-21 |
| Available |
: Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome : Lambert Eaton Myasthenic Syndrome : 2013-03-22 : Drug: 3, 4-Diaminopyridine |
| Completed |
: Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome : Lambert-Eaton Myasthenic Syndrome : 2000-02-24 : Drug: 3,4-diaminopyridine |
| Enrolling by invitation |
: Controlled Trial of 3,4-Diaminopyridine (3-4DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS) : Muscle Weakness : 2014-03-14 : Drug: 3-4 Diaminopyridine Other Name: 3-4 DAP |
| Recruiting |
: National Registry for Egyptian Pediatric Neuromuscular Diseases :
|